BWL
VRTX icon

Bogart Wealth LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Bogart Wealth LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Buy
27,196
+19
+0.1% +$8.86K 0.47% 47
2025
Q4 		$12.3M Buy
27,177
+1,028
+4% +$443K 0.49% 39
2025
Q3 		$10.2M Buy
26,149
+742
+3% +$310K 0.42% 58
2025
Q2 		$11.3M Buy
25,407
+6,240
+33% +$2.88M 0.48% 49
2025
Q1 		$9.29M Sell
19,167
-3,092
-14% -$1.44M 0.44% 54
2024
Q4 		$8.96M Buy
22,259
+3,031
+16% +$1.4M 0.43% 57
2024
Q3 		$8.94M Buy
19,228
+237
+1% +$114K 0.42% 57
2024
Q2 		$8.9M Buy
18,991
+509
+3% +$221K 0.45% 50
2024
Q1 		$7.73M Buy
18,482
+677
+4% +$286K 0.4% 64
2023
Q4 		$7.24M Buy
17,805
+1,501
+9% +$554K 0.41% 63
2023
Q3 		$5.67M Buy
16,304
+4,802
+42% +$1.68M 0.35% 71
2023
Q2 		$4.05M Buy
11,502
+293
+3% +$98.7K 0.26% 87
2023
Q1 		$3.53M Buy
11,209
+5,404
+93% +$1.62M 0.24% 90
2022
Q4 		$1.68M Buy
5,805
+5,732
+7,852% +$1.75M 0.12% 110
2022
Q3 		$21K Hold
73
– – ﹤0.01% 424
2022
Q2 		$21K Buy
+73
New +$19.5K ﹤0.01% 412

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bogart Wealth LLC's VRTX Position: Q1 2026 in Review

Bogart Wealth LLC increased its Vertex Pharmaceuticals (VRTX) stake by 0.07% in Q1 2026, buying an estimated $8.86K and bringing the position to 27,196 shares worth $12.1M. The position accounts for 0.47% of the portfolio, ranked #47.

Bogart Wealth LLC first reported a position in VRTX in Q2 2022 and has held it in 16 quarters since. The position peaked at $12.3M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Bogart Wealth LLC held 27,196 shares of Vertex Pharmaceuticals worth $12.1M as of Q1 2026.
  • Bogart Wealth LLC bought 19 Vertex Pharmaceuticals shares in Q1 2026, an estimated $8.86K.
  • Vertex Pharmaceuticals made up 0.47% of Bogart Wealth LLC's portfolio in Q1 2026, its #47 holding.
  • Bogart Wealth LLC first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
  • Bogart Wealth LLC's Vertex Pharmaceuticals position peaked at $12.3M in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.